Thomas Byrne is a Gastroenterology physician affiliated with Mayo Clinic in Arizona. OpenAlex indexes 71 publications with 2,250 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 852595452
Telephone
480-301-8000Provider last certified this registry record 5 Oct 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202413 payments$11,534openpaymentsdata.cms.gov ↗
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.5%Azole Antifungal18%Fluconazole100%Part D≥34 patientsShort-acting sulfonamides6.6%Sulfamethoxazole-Trimethoprim100%Part D≥20 patients+ 2 more classes in this area
Metabolism & gastrointestinal
31.9%Bile Acid10.4%Ursodiol100%Part D≥19 patientsCorticosteroid10.2%Prednisone100%Part D≥22 patients+ 2 more classes in this area
Cancer & immunology
25.5%Calcineurin inhibitor19.9%Tacrolimus100%Part D≥53 patientsPurine Antimetabolite5.7%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparative Assessment of Wastewater-Based Surveillance Normalization Methods to Improve Pathogen Monitoring in Rural Sewersheds
Environmental Science & Technology
2025 - Retrospective Analysis of Drinking Water Microcosm Microbiomes Reveals an Apparent Antagonistic Relationship between <i>Neochlamydia</i> and <i>Legionella</i>
Environmental Science & Technology Letters
2025 - Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report
Journal of Gastrointestinal Oncology
2025 - Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant
Journal of Gastrointestinal Cancer
2024
Similar KOLs
Other experts from the same institution or the same specialty.
John Dibaise, MD
Mayo Clinic in Arizona
Jonathan Leighton, MD
Mayo Clinic in Arizona
Suryakanth Gurudu, MD
Mayo Clinic in Arizona
Victor Trastek, MD
Mayo Clinic in Arizona
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”